Craft
  • Home
  •  / Biora Therapeutics
Biora Therapeutics

Biora Therapeutics

Patent Families for Molecular Testing Technology Patent Portfolio

17

FY, 2021

Revenue

$1.2 M

FY, 2021

Market Capitalization

$144.8 M

2022-07-08

Biora Therapeutics Summary

Company summary

Overview
Biora Therapeutics (formerly Progenity) is a company providing molecular and specialized diagnostic tests. It offers the Preparent Carrier Test for genetic diseases, the Innatal Prenatal Screen for chromosomal disorders, and the Riscover Hereditary Cancer Test for hereditary cancer risk. In addition, the company develops the Resura Prenatal Test for monogenic diseases.
Type
Public
Founded
2010
HQ
San Diego, CA, US | view all locations
Website
https://www.progenity.com/
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Kevin Howe

    Kevin Howe, Senior Vice President, Strategic Operations

  • Clarke Neumann

    Clarke Neumann, Senior Vice President, General Counsel and Secretary

    • Robyn Hatton

      Robyn Hatton, Vice President Human Resources

    • Eric d'Esparbes

      Eric d'Esparbes, Chief Financial Officer

      Operating MetricsView all

      Patents and Patent Applications

      350
      41.7%

      FY, 2021

      Patent Families for Molecular Testing Technology Patent Portfolio

      17

      FY, 2021

      Patent Families for Drug-Device and Diagnostics Device Patent Portfolio

      70

      FY, 2021

      LocationsView all

      4 locations detected

      • San Diego, CA HQ

        United States

        4330 La Jolla Village Dr #200

      • NY

        United States

        6201 15th Ave, Brooklyn

      • Ann Arbor, MI

        United States

        5230 S State Rd

      • Detroit, MI

        United States

        PO Box 674425

      Biora Therapeutics Financials

      Summary financials

      Footer menu